| Warzenmittel und Keratolytika (D11AF) | Contenu | Cat | PR courant | QD | Prix u. | |
|---|---|---|---|---|---|---|
ENDWARTS Pen (0 )
MEDA Pharma GmbH • solution externe |
3 ml | k.a. | k.a. | |||
WORTIE COOL Traitement contre verrues (0 )
ebi-pharm ag • spray externe |
50 ml | k.a. | k.a. | |||
ENDWARTS Freeze
MEDA Pharma GmbH • spray externe |
7.5 g | k.a. | k.a. | |||
MOLUSK sol cutanée (100 mg)
Pierre Fabre Pharma AG • solution externe |
3 g | k.a. | k.a. | |||
WARZIN contre les verrues
Bano Healthcare GmbH • solution externe |
10 ml | 11.50 CHF | 1.15 CHF | |||
Tacrolimus (D11AH01) |
||||||
Protopic® (0.03 %)
LEO Pharmaceutical Products Sarath Ltd. • pommade |
30 g | B | 49.05 CHF | 1.64 CHF | ||
Protopic® (0.03 %)
LEO Pharmaceutical Products Sarath Ltd. • pommade |
60 g | B | 73.75 CHF | 1.23 CHF | ||
Protopic® (0.1 %)
LEO Pharmaceutical Products Sarath Ltd. • pommade |
30 g | B | 52.60 CHF | 1.75 CHF | ||
Protopic® (0.1 %)
LEO Pharmaceutical Products Sarath Ltd. • pommade |
60 g | B | 80.00 CHF | 1.33 CHF | ||
Tacrocutan® Pommade (1 mg/g)
Dermapharm AG • pommade |
30 g | B | k.a. | k.a. | ||
Tacrocutan® Pommade (1 mg/g)
Dermapharm AG • pommade |
60 g | B | k.a. | k.a. | ||
Pimecrolimus (D11AH02) |
||||||
Elidel® 1% crème (1 %)
MEDA Pharma GmbH • crème |
30 g | B | 48.85 CHF | 1.63 CHF | ||
Elidel® 1% crème (1 %)
MEDA Pharma GmbH • crème |
60 g | B | 73.35 CHF | 1.22 CHF | ||
Alitrétinoïne (D11AH04) |
||||||
Toctino (10 mg)
GlaxoSmithKline AG • capsules molles |
30 pce | A | 562.25 CHF | 18.74 CHF | ||
Toctino (30 mg)
GlaxoSmithKline AG • capsules molles |
30 pce | A | 562.25 CHF | 18.74 CHF | ||
Dupilumab (D11AH05) |
||||||
Dupixent®, solution injectable en seringue préremplie avec système de sécurité (300 mg/2m)
Sanofi-Aventis (Suisse) SA • solution injectable |
2 pce | B | 1273.85 CHF | 636.92 CHF | ||
Dupixent®, solution injectable en seringue préremplie avec système de sécurité (200 mg/1.)
Sanofi-Aventis (Suisse) SA • solution injectable |
2 pce | B | 1273.85 CHF | 636.92 CHF | ||
Dupixent®, solution injectable en stylo pré-rempli (200 mg/1.)
Sanofi-Aventis (Suisse) SA • solution injectable |
2 pce | B | 1273.85 CHF | 636.92 CHF | ||
Dupixent®, solution injectable en stylo pré-rempli (300 mg/2m)
Sanofi-Aventis (Suisse) SA • solution injectable |
2 pce | B | 1273.85 CHF | 636.92 CHF | ||
Tralokinumab (D11AH07) |
||||||
Adtralza® (150 mg/ml)
LEO Pharmaceutical Products Sarath Ltd. • solution injectable |
2x2 pce | B | 1298.40 CHF | 649.20 CHF | ||
Abrocitinib (D11AH08) |
||||||
Cibinqo® (50 mg)
Pfizer AG • comprimés pelliculés |
28 pce | B | 1218.25 CHF | 43.51 CHF | ||
Cibinqo® (100 mg)
Pfizer AG • comprimés pelliculés |
28 pce | B | 1218.25 CHF | 43.51 CHF | ||
Autres produits dermatologiques (D11AX) |
||||||
Kamillex®, liquide
Streuli Pharma AG • solution externe |
100 ml | D | 6.65 CHF | 0.07 CHF | ||
Kamillex®, liquide
Streuli Pharma AG • solution externe |
200 ml | D | 11.70 CHF | 0.06 CHF | ||
Kamillex®, liquide
Streuli Pharma AG • solution externe |
500 ml | D | k.a. | k.a. | ||
Bite-X (159 mg)
Doetsch Grether AG • solution externe |
15 ml | D | k.a. | k.a. | ||
Tannosynt® liquide (400 mg)
Almirall AG • solution externe |
100 g | D | 8.20 CHF | 0.08 CHF | ||
PROFHILO sol inj (64 mg)
IBSA Institut Biochimique SA • solution injectable |
2 ml | k.a. | k.a. | |||
ALIAXIN SR sol inj (25 mg)
IBSA Institut Biochimique SA • solution injectable |
2x1 ml | k.a. | k.a. | |||
ALIAXIN FL sol inj (25 mg)
IBSA Institut Biochimique SA • solution injectable |
2x1 ml | k.a. | k.a. | |||
ALIAXIN GP sol inj (25 mg)
IBSA Institut Biochimique SA • solution injectable |
2x1 ml | k.a. | k.a. | |||
ALIAXIN EV sol inj (25 mg)
IBSA Institut Biochimique SA • solution injectable |
2x1 ml | k.a. | k.a. | |||
VISCODERM Hydrobooster sol inj (25 mg)
IBSA Institut Biochimique SA • solution injectable |
1.1 ml | k.a. | k.a. | |||
ALIAXIN SV sol inj (25 mg)
IBSA Institut Biochimique SA • solution injectable |
2 ml | k.a. | k.a. | |||
SCULPTRA New-Fill subst sèche (150 mg)
Galderma SA • substance sèche |
2 pce | k.a. | k.a. | |||
ALIAXIN LV sol inj (25 mg)
IBSA Institut Biochimique SA • solution injectable |
2x1 ml | k.a. | k.a. | |||
Minoxidil, topique (D11AX01) |
||||||
Regaine® 2% (2 %)
Janssen-Cilag AG • solution externe |
60 ml | D | k.a. | k.a. | ||
Regaine® 2% (2 %)
Janssen-Cilag AG • solution externe |
3x60 ml | D | k.a. | k.a. | ||
Regaine® 5% (5 %)
Janssen-Cilag AG • solution externe |
60 ml | D | k.a. | k.a. | ||
Regaine® 5% (5 %)
Janssen-Cilag AG • solution externe |
3x60 ml | D | k.a. | k.a. | ||